For immunochemical detection of cytokeratin 14
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Cytokeratin 14 (C-Term) Rabbit Monoclonal Antibody (Clone RM328)

Item No. 32266

Technical Information
Synonyms
  • CK-14
  • Keratin-14
  • Keratin, Type II Cytoskeletal 14
  • KRT14
Immunogen
Peptide from the C-terminal region of human cytokeratin 14
Clone Designation
RM328
100 µl of protein A-affinity purified monoclonal antibody
Storage Buffer
PBS with 50% glycerol, 1% BSA, and 0.09% sodium azide
Host
Rabbit
Isotype
IgG
Applications
IHC and WB
Cross Reactivity
(+) Cytokeratin 14
Species Reactivity
(+) Human
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Cytokeratin 14 (CK-14) is a type I acidic epithelial intermediate filament protein.1 It is composed of a central rod containing four α-helical domains, which are important for self-assembly, and non-helical head and tail domains at the N- and C-termini, respectively.2,3 CK-14 is expressed in stratified squamous epithelial cells, keratinocytes, and myoepithelial cells in the basal layer of the epidermis and is an integral component of the epithelial cell cytoskeleton.1,4,5 It dimerizes with the type II basic epithelial intermediate filament protein CK-5 via heptad repeats in the central rod domain to form a network of filament bundles throughout the cytoplasm.2,3 Increased tumor levels of CK-14 have been found in patients with squamous cell carcinomas of the bladder, lung, or cervix.6 Mutations in the gene encoding CK-14 have been found in patients with epidermolysis bullosa simplex (EBS), a disorder characterized by skin blistering.7 Cayman's Cytokeratin 14 (C-Term) Rabbit Monoclonal Antibody (Clone RM328) can be used for immunohistochemistry (IHC) and Western blot (WB) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Asano-Miyoshi, M., Hamamichi, R., and Emori, Y. Cytokeratin 14 is expressed in immature cells in rat taste buds. J. Mol. Histol. 39(2), 193-199 (2008).

    2. Bousquet, O., Ma, L., Yamada, S., et alThe nonhelical tail domain of keratin 14 promotes filament bundling and enhances the mechanical properties of keratin intermediate filaments in vitro. J. Cell. Biol. 155(5), 747-754 (2001).

    3. Lee, C.-H., Kim, M.-S., Chung, B.M., et alStructural basis for heteromeric assembly and perinuclear organization of keratin filaments. Nat. Struct. Mol. Biol. 19(7), 707-715 (2012).

    4. Törmä, H. Regulation of keratin expression by retinoids. Dermatoendocrinol. 3(3), 136-140 (2011).

    5. Reis-Filho, J.S., Simpson, P.T., Martins, A., et alDistribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 443(2), 122-132 (2003).

    6. Chu, P.G., Lyda, M.H., and Weiss, L.M. Cytokeratin 14 expression in epithelial neoplasms: A survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology 39(1), 9-16 (2001).

    7. Atkinson, S.D., McGilligan, V.E., Liao, H., et alDevelopment of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J. Invest. Dermatol. 131(10), 2079-2086 (2011).